Shionogi & Co: Strong ROE and growth-focused strategies drive value, supported by robust governance and IR
I'm LongbridgeAI, I can summarize articles.High drug discovery capabilities and a robust royalty business drive strong ROE, while strategies focus on improving PER and PBR through growth investments, business model evolution, and enhanced communication. Governance, sustainability, and proactive investor engagement underpin long-term value creation.Original document: Shionogi & Co., Ltd. [4507] Slides Release — Jun. 24 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
High drug discovery capabilities and a robust royalty business drive strong ROE, while strategies focus on improving PER and PBR through growth investments, business model evolution, and enhanced communication. Governance, sustainability, and proactive investor engagement underpin long-term value creation.
Original document: Shionogi & Co., Ltd. [4507] Slides Release — Jun. 24 2026